首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   3368645篇
  免费   249983篇
  国内免费   8849篇
耳鼻咽喉   45579篇
儿科学   110099篇
妇产科学   91828篇
基础医学   473875篇
口腔科学   94281篇
临床医学   308935篇
内科学   661852篇
皮肤病学   77210篇
神经病学   277689篇
特种医学   130974篇
外国民族医学   952篇
外科学   503481篇
综合类   72814篇
现状与发展   5篇
一般理论   1290篇
预防医学   265908篇
眼科学   74822篇
药学   246771篇
  11篇
中国医学   6625篇
肿瘤学   182476篇
  2019年   26128篇
  2018年   36872篇
  2017年   28288篇
  2016年   32555篇
  2015年   36718篇
  2014年   50873篇
  2013年   76861篇
  2012年   101673篇
  2011年   107841篇
  2010年   64994篇
  2009年   62219篇
  2008年   100580篇
  2007年   107094篇
  2006年   108874篇
  2005年   104692篇
  2004年   100901篇
  2003年   97305篇
  2002年   93728篇
  2001年   162000篇
  2000年   166434篇
  1999年   140015篇
  1998年   40416篇
  1997年   35942篇
  1996年   36401篇
  1995年   35379篇
  1994年   32643篇
  1993年   30535篇
  1992年   110361篇
  1991年   106559篇
  1990年   103229篇
  1989年   99375篇
  1988年   91298篇
  1987年   89710篇
  1986年   84399篇
  1985年   80649篇
  1984年   60415篇
  1983年   51126篇
  1982年   30392篇
  1981年   27226篇
  1979年   53904篇
  1978年   38298篇
  1977年   32326篇
  1976年   30018篇
  1975年   32039篇
  1974年   38015篇
  1973年   36265篇
  1972年   33872篇
  1971年   31440篇
  1970年   28912篇
  1969年   27510篇
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
41.
42.

Background

Chronic limb-threatening ischemia (CLTI), defined as ischemic rest pain or tissue loss secondary to arterial insufficiency, is caused by multilevel arterial disease with frequent, severe infrageniculate disease. The rise in CLTI is in part the result of increasing worldwide prevalence of diabetes, renal insufficiency, and advanced aging of the population. The aim of this study was to compare a bypass-first with an endovascular-first revascularization strategy in patients with CLTI due to infrageniculate arterial disease.

Methods

We reviewed the American College of Surgeons National Surgical Quality Improvement Program targeted lower extremity revascularization database from 2012 to 2015 to identify patients with CLTI and isolated infrageniculate arterial disease who underwent primary infrageniculate bypass or endovascular intervention. We excluded patients with a history of ipsilateral revascularization and proximal interventions. The end points were major adverse limb event (MALE), major adverse cardiovascular event (MACE), amputation at 30 days, reintervention, patency, and mortality. Multivariable logistic regression was used to determine the association of a bypass-first or an endovascular-first intervention with outcomes.

Results

There were 1355 CLTI patients undergoing first-time revascularization to the infrageniculate arteries (821 endovascular-first revascularizations and 534 bypass-first revascularizations) identified. There was no significant difference in adjusted rate of 30-day MALE in the bypass-first vs endovascular-first revascularization cohort (9% vs 11.2%; odds ratio [OR], 0.73; 95% confidence interval [CI], 0.50-1.08). However, the incidence of transtibial or proximal amputation was lower in the bypass-first cohort (4.3% vs 7.4%; OR, 0.60; CI, 0.36-0.98). Patients with bypass-first revascularization had higher wound complication rates (9.7% vs 3.7%; OR, 2.75; CI, 1.71-4.42) compared with patients in the endovascular-first cohort. Compared with the endovascular-first cohort, the incidence of 30-day MACE was significantly higher in bypass-first patients (6.9% vs 2.6%; adjusted OR, 3.88; CI, 2.18-6.88), and 30-day mortality rates were 3.23% vs 1.8% (adjusted OR, 2.77; CI, 1.26-6.11). There was no difference in 30-day untreated loss of patency, reintervention of treated arterial segment, readmissions, and reoperations between the two cohorts. In subgroup analysis after exclusion of dialysis patients, there was also no significant difference in MALE or amputation between the bypass-first and endovascular-first cohorts.

Conclusions

CLTI patients with isolated infrageniculate arterial disease treated by a bypass-first approach have a significantly lower 30-day amputation. However, this benefit was not observed when dialysis patients were excluded. The bypass-first cohort had a higher incidence of MACE compared with an endovascular-first strategy. These results reaffirm the need for randomized controlled trials, such as the Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL-2) trial and Best Endovascular vs Best Surgical Therapy in Patients with Critical Limb Ischemia (BEST-CLI), to provide level 1 evidence for the role of endovascular-first vs bypass-first revascularization strategies in the treatment of this population of challenging patients.  相似文献   
43.
We report the case of a littoral‐cell angioma of the spleen, a recently described benign vascular tumour, whose imaging and pathological characteristics have been discussed only by a few authors. The diagnosis was made after elective splenectomy. The CT images, scintigraphy and histological specimens are presented, and differential diagnoses discussed.  相似文献   
44.
45.
46.
Conclusion  Several quality-control measures take place before (patient and camera preparation) and during SPECT acquisition to achieve high-quality images. Not uncommonly, technologists and physicians are left with suboptimal images that have to be addressed to reach the “right answer” for patient diagnosis and hence management. In many cases patients may be reimaged, especially if the problem is detected early, but in other cases either the patient has left the nuclear laboratory or there is an inevitable problem that, even with reimaging, will not be resolved. In these situations the technologist and physician have to seek the available techniques to obtain the best images possible. These resources are discussed in this issue as an aid in quality control to obtain the best possible images.  相似文献   
47.
48.
49.
50.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号